Get started
Author

М. S. Pantyushenko

Observed names: M. Pantyushenko, M. S. Pantyushenko, M.S. Pantyushenko, Marina Pantyushenko, Marina S. Pantyushenko, М. С. Пантюшенко
Observed institution: Generium Pharmaceuticals (Russia)
ORCID: 0000-0002-2766-2560
Observed ORCID: 0000-0002-2766-2560
OpenAlex ID: A5057838409
Physico-Chemical and Biological Properties of Biosimilar and Reference Tissue Plasminogen Activator Products
2019 · V. D. Gusarova, M. S. Pantyushenko, et al. · Biological Products Prevention Diagnosis Treatment · 11
PDF
Characterization of a HIR-Fab-IDS, Novel Iduronate 2-Sulfatase Fusion Protein for the Treatment of Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome)
2023 · Valentina D. Gusarova, Maxim A. Smolov, et al. · BioDrugs · 8
Results of a phase I open randomized comparative crossover clinical trial to assess the safety and pharmacokinetics of Glurazyme® (imiglucerase) in comparison with the reference product in healthy volunteers
2019 · S. B. Fitilev, A. V. Vozzhaev, et al. · Oncohematology · 6
Increasing productivity of arylsulfatase B-producing cell line by coexpression of formylglycine-generating enzyme
2022 · S. S. Timonova, K. A. Smolova, et al. · Biological Products Prevention Diagnosis Treatment · 4
PDF
A Study of the Comparability of the Pharmacodynamic, Toxicological, and Pharmacokinetic Properties of the Reference Drug Pulmozyme® and the Biosimilar Drug Tigerase®
2024 · M. S. Aksenova, E. N. Bocharova, et al. · Doklady Biochemistry and Biophysics · 3
Comparability of the Reference Drug Pulmozim and a Similar Drug Tigerase in Terms of their Pharmacodynamic, Toxicological and Pharmacokinetic Properties
2023 · M. S. Aksenova, E. N. Bocharova, et al. · Journal Biomed · 2
PDF
Optimization of the Cultivation Processof a Producer Clone of the Recombinant Lysosomal Iduronate-2-sulfatase Enzyme
2021 · M.S. Pantyushenko, R.V. Tikhonov, et al. · Biotekhnologiya · 2
Optimisation of culture conditions for a producer clone coexpressing arylsulfatase B and a formylglycine-generating enzyme in order to increase the yield of arylsulfatase B
2022 · S. S. Timonova, K. A. Smolova, et al. · Biological Products Prevention Diagnosis Treatment · 1
PDF
Development and Validation of a Biolayer Interferometry Method for Determination of Human Anti-PD-1 Monoclonal Antibody Concentration in Cynomolgus Serum
2020 · K. V. Ulyanova, A. A. Kazarov, et al. · Biological Products Prevention Diagnosis Treatment · 1
Разработка и валидация методики определения концентрации экулизумаба в плазме крови человека с применением технологии биослойной интерферометрии
2017 · В. М. Симонов, М. С. Пантюшенко, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
An Open-Label, Comparative, Parallel Clinical Trial of the Safety, Pharmacokinetics and Immunogenicity of the Ustekinumab Biosimilar GNR-068 and the Originally Developed Ustekinumab as a Reference Drug After a Single Subcutaneous Administration in Healthy Male Volunteers
2026 · Ivan Lyagoskin, Alena Agafonova, et al. · Antibodies
Сопоставимость функциональных свойств разрабатываемого биоаналогичного препарата GNR-069 и референтного лекарственного препарата Энплейт® in vitro
2023 · S. Abbasova, O. Strizhakova, et al. · Биофармацевтический журнал
Internalization of Recombinant Imiglucerase into Mouse Peritoneal Macrophages and L929 Mouse Fibroblasts
2020 · I. V. Lyagoskin, M. S. Pantyushenko, et al. · Biological Products Prevention Diagnosis Treatment
PDF
Works count: 13
Citation count: 39
H-index: 4
I10-index: 1
Year
Topic
Type